Edward M. Sellers

38.3k total citations · 3 hit papers
423 papers, 28.5k citations indexed

About

Edward M. Sellers is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Edward M. Sellers has authored 423 papers receiving a total of 28.5k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Cellular and Molecular Neuroscience, 85 papers in Pharmacology and 81 papers in Molecular Biology. Recurrent topics in Edward M. Sellers's work include Neurotransmitter Receptor Influence on Behavior (86 papers), Pharmacogenetics and Drug Metabolism (77 papers) and Opioid Use Disorder Treatment (39 papers). Edward M. Sellers is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (86 papers), Pharmacogenetics and Drug Metabolism (77 papers) and Opioid Use Disorder Treatment (39 papers). Edward M. Sellers collaborates with scholars based in Canada, United States and United Kingdom. Edward M. Sellers's co-authors include U. Busto, C. A. Naranjo, Paul Sandor, E Janecek, E A Roberts, C Domecq, Inés Ruiz, D J Greenblatt, Jan Koch‐Weser and Rachel F. Tyndale and has published in prestigious journals such as New England Journal of Medicine, The Lancet and American Journal of Psychiatry.

In The Last Decade

Edward M. Sellers

412 papers receiving 26.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A method for estimating the probability of adverse drug reactions

1981 8.4k citations Edward M. Sellers et al. Clinical Pharmacology & Therapeutics profile →
Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA‐Ar)

1989 1.4k citations Edward M. Sellers et al. profile →
Research Advances in Alcohol and Drug Problems

1984 764 citations Edward M. Sellers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward M. Sellers Canada	73	4.9k	4.9k	4.5k	4.0k	3.6k	423	28.5k
David J. Greenblatt United States	92	6.1k 1.2×	4.0k 0.8×	3.9k 0.9×	9.1k 2.3×	6.0k 1.7×	832	34.9k
Richard I. Shader United States	81	4.0k 0.8×	3.6k 0.7×	1.9k 0.4×	5.2k 1.3×	5.5k 1.5×	549	21.5k
Gerd Geißlinger Germany	77	5.9k 1.2×	3.3k 0.7×	8.1k 1.8×	2.5k 0.6×	1.4k 0.4×	591	24.1k
Silvio Garattini Italy	67	2.6k 0.5×	6.0k 1.2×	4.2k 0.9×	1.4k 0.3×	1.7k 0.5×	752	19.2k
Neal L. Benowitz United States	108	4.6k 0.9×	2.8k 0.6×	12.9k 2.8×	1.9k 0.5×	1.3k 0.4×	677	47.3k
Thomas R. Kosten United States	77	3.9k 0.8×	7.3k 1.5×	3.7k 0.8×	241 0.1×	3.9k 1.1×	567	22.9k
Meindert Danhof Netherlands	61	2.7k 0.5×	2.3k 0.5×	3.5k 0.8×	2.4k 0.6×	1.7k 0.5×	496	15.3k
Bruno H. Stricker Netherlands	90	2.1k 0.4×	559 0.1×	3.7k 0.8×	1.6k 0.4×	2.2k 0.6×	571	30.4k
Richard M. Weinshilboum United States	77	1.8k 0.4×	1.9k 0.4×	8.7k 1.9×	5.0k 1.3×	1.7k 0.5×	408	23.9k
Urs Meyer Switzerland	101	2.0k 0.4×	2.2k 0.5×	8.9k 2.0×	10.2k 2.5×	1.7k 0.5×	378	31.4k

Countries citing papers authored by Edward M. Sellers

Since Specialization

Citations

This map shows the geographic impact of Edward M. Sellers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward M. Sellers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward M. Sellers more than expected).

Fields of papers citing papers by Edward M. Sellers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward M. Sellers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward M. Sellers. The network helps show where Edward M. Sellers may publish in the future.

Co-authorship network of co-authors of Edward M. Sellers

This figure shows the co-authorship network connecting the top 25 collaborators of Edward M. Sellers. A scholar is included among the top collaborators of Edward M. Sellers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward M. Sellers. Edward M. Sellers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sellers, Edward M.. (2025). Tutorial Drug–Drug Interactions. Clinical and Translational Science. 19(1). e70458–e70458.

Sellers, Edward M. & Myroslava K. Romach. (2023). Psychedelics: Science sabotaged by Social Media. Neuropharmacology. 227. 109426–109426. 9 indexed citations

Sellers, Edward M.. (2017). Improving the Clinical Pharmacologic Assessment of Abuse Potential. Journal of Clinical Psychopharmacology. 38(1). 11–18. 1 indexed citations

Argoff, Charles E., Meldon Kahan, & Edward M. Sellers. (2014). Preventing and managing aberrant drug-related behavior in primary care: Systematic review of outcomes evidence. Journal of Opioid Management. 10(2). 119–134. 23 indexed citations

Sellers, Edward M., Kerri A. Schoedel, Myroslava K. Romach, et al.. (2013). A Multiple‐Dose, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray. Clinical Pharmacology in Drug Development. 2(3). 285–294. 29 indexed citations

Schoedel, Kerri A., et al.. (2011). Reduced cognitive and psychomotor impairment with extended-release oxymorphone versus controlled-release oxycodone.. PubMed. 13(6). 561–73. 12 indexed citations

Chu, William, Anthony Fyles, Edward M. Sellers, et al.. (2007). Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use. Carcinogenesis. 28(10). 2139–2142. 29 indexed citations

Schoedel, Kerri A., et al.. (2004). Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics. 14(9). 615–626. 238 indexed citations

Keung, Anther, Teddy Kosoglou, Paul Statkevich, et al.. (2001). Ezetimibe does not affect the pharmacokinetics of oral contraceptives. Clinical Pharmacology & Therapeutics. 69(2). 55. 27 indexed citations

10.

Sproule, Beth, S. Victoria Otton, Siu Wah Cheung, et al.. (1997). CYP2D6 Inhibition in Patients Treated With Sertraline. Journal of Clinical Psychopharmacology. 17(2). 102–106. 54 indexed citations

11.

Higgins, Guy A., Narges Joharchi, Peter Nguyen, & Edward M. Sellers. (1992). Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning. Psychopharmacology. 106(3). 315–320. 77 indexed citations

12.

Somer, Gail, et al.. (1992). Characteristics of Long-term Alprazolam Users in the Community. Journal of Clinical Psychopharmacology. 12(5). 316???321–316???321. 21 indexed citations

13.

Sellers, Edward M., et al.. (1985). Research advances in new psychopharmacological treatments for alcoholism : proceedings of the symposium "Research advances in New Psychopharmacological Treatments for Alcoholism," Toronto, 4-5 October 1984. Elsevier eBooks. 8 indexed citations

14.

Sellers, Edward M., et al.. (1982). Mechanisms of ethanol drug interactions. Clinical and investigative medicine. 5. 5.

15.

Sellers, Edward M., et al.. (1979). Use of drugs with dependence liability.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 121(6). 717–22, 724. 1 indexed citations

16.

Barnsley, Janet & Edward M. Sellers. (1978). An Interview Study of Hospitalized Drug Overdose Patients. Canadian Family Physician. 24. 850–856. 1 indexed citations

17.

Sellers, Edward M.. (1978). Clinical pharmacology and therapeutics of benzodiazepines.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 118(12). 1533–8. 48 indexed citations

18.

Giles, H. G., et al.. (1978). Probable interaction of loperamide and cholestyramine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 119(6). 607–8. 6 indexed citations

19.

Sellers, Edward M. & Jan Koch‐Weser. (1971). KINETICS AND CLINICAL IMPORTANCE OF DISPLACEMENT OF WARFARIN FROM ALBUMIN BY ACIDIC DRUGS*. Annals of the New York Academy of Sciences. 179(1). 213–225. 88 indexed citations

20.

Sellers, Edward M.. (1965). THE INFLUENCES OF GROUP AND INDEPENDENT GENERAL PRACTICE ON PATIENT CARE: A COMPARATIVE STUDY IN ONTARIO.. PubMed. 93. 147–57. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact